Bright Minds Biosciences Inc.
DRUGHealthcare|Biotechnology|US
$23.00
+2.30 (+11.11%)
DCF Value
$8.39
Tangible Book / Share
$31.35
Cash / Share
$31.35
Clinical Trials (3)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT06401538 BMB-101 in Absence Epilepsy and DEE | Absence Epilepsy, Jeavons Syndrome | P2 | Recruiting | 20 | Open-label | BMB-101 |
| NCT07266324 A 2-Part Study to Assess Efficacy, Safety and Tolerability of BMB-101 for the Treatment of Patients With Prader-Willi Syndrome. | Prader-Willi Syndrome | P2 | Not Yet Recruiting | 16 | RCT, Double-blind | BMB-101, Placebo |
| NCT05397041 A 3-Part Study to Evaluate the Safety, Tolerability, PK, and Food Effect of BMB-101 in Healthy Volunteers | Healthy | P1 | Completed | 81 | RCT, Double-blind | BMB-101, Placebo |